HR 6101 · 117th Congress · Health

Drug Price Transparency in Medicaid Act of 2021

Introduced 2021-12-01· Sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1]· House

Bill Progress

Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2021-12-02)

Plain Language Summary

[AI summary unavailable — showing source text] Drug Price Transparency in Medicaid Act of 2021 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (4)

1 Democrat3 Republicans